BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19250986)

  • 1. Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis.
    Loomba R; Wesley R; Bain A; Csako G; Pucino F
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):487-493. PubMed ID: 19250986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding.
    Cohen MJ; Sahar T; Benenson S; Elinav E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004791. PubMed ID: 19370611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis.
    Mo S; Bendtsen F; Wiese SS; Kimer N
    Scand J Gastroenterol; 2018 Feb; 53(2):200-205. PubMed ID: 29214880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis.
    Saab S; Hernandez JC; Chi AC; Tong MJ
    Am J Gastroenterol; 2009 Apr; 104(4):993-1001; quiz 1002. PubMed ID: 19277033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
    Das A
    Am J Gastroenterol; 1998 Oct; 93(10):1895-900. PubMed ID: 9772051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis.
    Mücke MM; Mücke VT; Graf C; Schwarzkopf KM; Ferstl PG; Fernandez J; Zeuzem S; Trebicka J; Lange CM; Herrmann E
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00223. PubMed ID: 32955202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C; Kumar A; Sarin SK
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics for prophylaxis of spontaneous bacterial peritonitis: systematic review & Bayesian network meta-analysis.
    Soni H; Kumar-M P; Sharma V; Bellam BL; Mishra S; Mahendru D; Mandavdhare HS; Medhi B; Dutta U; Singh V
    Hepatol Int; 2020 May; 14(3):399-413. PubMed ID: 32266675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Hanouneh MA; Hanouneh IA; Hashash JG; Law R; Esfeh JM; Lopez R; Hazratjee N; Smith T; Zein NN
    J Clin Gastroenterol; 2012 Sep; 46(8):709-15. PubMed ID: 22878533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis.
    Frazee LA; Marinos AE; Rybarczyk AM; Fulton SA
    Ann Pharmacother; 2005 May; 39(5):908-12. PubMed ID: 15769829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
    Assem M; Elsabaawy M; Abdelrashed M; Elemam S; Khodeer S; Hamed W; Abdelaziz A; El-Azab G
    Hepatol Int; 2016 Mar; 10(2):377-85. PubMed ID: 26660707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prophylactic antibiotic regimens on recurrence and mortality in spontaneous bacterial peritonitis.
    Glaess SS; Attridge RL; Brady RL; Attridge RT
    Ann Hepatol; 2019; 18(6):841-848. PubMed ID: 31611065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Sandhu BS; Gupta R; Sharma J; Singh J; Murthy NS; Sarin SK
    J Gastroenterol Hepatol; 2005 Apr; 20(4):599-605. PubMed ID: 15836710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis-study protocol for an interventional randomised controlled trial.
    Crocombe D; Ahmed N; Balakrishnan I; Bordea E; Chau M; China L; Corless L; Danquah V; Dehbi HM; Dillon JF; Forrest EH; Freemantle N; Gear DP; Hollywood C; Hunter R; Jeyapalan T; Kallis Y; McPherson S; Munteanu I; Portal J; Richardson P; Ryder SD; Virk A; Wright G; O'Brien A
    Trials; 2022 Sep; 23(1):812. PubMed ID: 36167573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin.
    Marciano S; Dirchwolf M; Diaz JM; Bermudez C; Gutierrez-Acevedo MN; Barcán LA; Smud A; Giunta D; Gadano AC
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):540-546. PubMed ID: 30557229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis.
    Inadomi J; Sonnenberg A
    Gastroenterology; 1997 Oct; 113(4):1289-94. PubMed ID: 9322524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Rifaximin in Spontaneous Bacterial Peritonitis Prevention.
    Oliver A; Wong M; Sanchez C
    South Med J; 2018 Nov; 111(11):660-665. PubMed ID: 30392000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.
    Goel A; Rahim U; Nguyen LH; Stave C; Nguyen MH
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1029-1036. PubMed ID: 28994123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of long-term antibiotic treatments in the primary prophylaxis of spontaneous bacterial peritonitis.
    Facciorusso A; Papagiouvanni I; Cela M; Buccino VR; Sacco R
    Liver Int; 2019 Aug; 39(8):1448-1458. PubMed ID: 30920712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.
    Lutz P; Parcina M; Bekeredjian-Ding I; Nischalke HD; Nattermann J; Sauerbruch T; Hoerauf A; Strassburg CP; Spengler U
    PLoS One; 2014; 9(4):e93909. PubMed ID: 24714550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.